Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Basic tumor immunology

Original research

Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation

Online download statistics by month:

Online download statistics by month: October 2022 to August 2024

	Abstract	Full	Pdf
Oct 2022	477	482	272
Nov 2022	878	882	417
Dec 2022	486	489	145
Jan 2023	261	264	86
Feb 2023	274	277	98
Mar 2023	259	259	91
Apr 2023	242	246	112
May 2023	287	289	126
Jun 2023	321	323	144
Jul 2023	257	258	97
Aug 2023	273	276	85
Sep 2023	294	295	109
Oct 2023	187	187	108
Nov 2023	318	318	149
Dec 2023	255	256	155
Jan 2024	256	265	185
Feb 2024	146	147	91
Mar 2024	491	498	209
Apr 2024	225	230	139
May 2024	222	226	154
Jun 2024	220	222	112
Jul 2024	263	264	116
Aug 2024	186	183	106
Total	7078	7136	3306